Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help of advanced modern RT and imaging technologies. Currently, SBRT is recommended as an alternative to curative treatments, such as surgery and radiofrequency ablation. This review discusses the current status of SBRT to aid in the decision making on how it is incorporated into the HCC management.
Citations
Citations to this article as recorded by
Dosimetric Comparison Study Between Free Breathing and Breath Hold Techniques in Patients Treated by Liver-Directed Stereotactic Body Radiation Therapy Atsuto Katano, Tomoyuki Noyama, Kosuke Morishima, Yuki Nozawa, Hideomi Yamashita Cureus.2023;[Epub] CrossRef
The role of stereotactic body radiotherapy (SBRT) in the treatment of recurrent / progressive lung lesions after primary treatment H. Demir, S. Özdemir, N. Işık, G. Yaprak International Journal of Radiation Research.2023; 21(4): 727. CrossRef
MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review Mohanned Alnammi, Jeremy Wortman, Jaclyn Therrien, Jalil Afnan Abdominal Radiology.2022; 47(7): 2299. CrossRef
Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis Shan Jin, Shisheng Tan, Wen Peng, Ying Jiang, Chunshan Luo World Journal of Surgical Oncology.2020;[Epub] CrossRef